Skip to Navigation
Skip to Main Content
Skip to Related Content

Advertisement

U.S. Markets open in 4 hrs 8 mins

S&P Futures
3,857.75
+9.50(+0.25%)
Dow Futures
31,091.00
+78.00(+0.25%)
Nasdaq Futures
11,929.75
+49.50(+0.42%)
Russell 2000 Futures
1,734.40
+5.80(+0.34%)
Crude Oil
98.44
-0.09(-0.09%)
Gold
1,739.90
+3.40(+0.20%)

Advertisement

Beam Therapeutics Inc. (BEAM)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Add to watchlist

Visitors trend2W10W9M

45.56

-0.93

(-2.00%)

At close: 04:00PM EDT

44.96

-0.60

(-1.32%)

After hours:

07:44PM EDT

Advertisement

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Neutralpattern detected

View all chart patterns

Performance Outlook

Previous Close	46.49
Open	46.44
Bid	0.00 x 1100
Ask	0.00 x 1800
Day's Range	44.83 - 49.06
52 Week Range	27.77 - 116.91
Volume	1,281,808
Avg. Volume	1,378,515

Market Cap	3.104B
Beta (5Y Monthly)	1.22
PE Ratio (TTM)	N/A
EPS (TTM)	-6.54
Earnings Date	Mar 14, 2022 - Mar 18, 2022
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	99.20

All

Motley Fool
Have $1,000 to Invest? 2 Stocks to Buy Right Now That Could Help Make You a Fortune
Protracted drawdowns in the stock market are unnerving, to say the least. Two of my personal favorites in this buyer's market are AMC Entertainment Holdings (NYSE: AMC) and Beam Therapeutics (NASDAQ: BEAM). AMC Entertainment Holdings' underlying fundamentals and near-term growth prospects aren't going to win over many classic value investors.
- Movies on the Big Screen Are $5 on Discount Tuesdays at All AMC Theatres U.S. Locations Through the End of October
  Business Wire
- AMC Theaters Brings Back Discount Tuesdays Through October
  CBS-Philadelphia
GlobeNewswire
Beam Therapeutics to Present First Research Highlighting Approach to Develop Non-Genotoxic Conditioning Regimens for Patients with Sickle Cell Disease Ahead of Autologous Transplant
CAMBRIDGE, Mass., June 27, 2022 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that new research highlighting the company’s internal efforts to develop improved transplant conditioning regimens for patients with sickle cell disease (SCD) undergoing hematopoietic stem cell transplantation (HSCT) will be presented today, June 27, 2022, at 4:00 p.m. CEST at the Federation of American Soc
Simply Wall St.
How Much Of Beam Therapeutics Inc. (NASDAQ:BEAM) Do Institutions Own?
A look at the shareholders of Beam Therapeutics Inc. ( NASDAQ:BEAM ) can tell us which group is most powerful...